BRIEF-Biocryst announces Rapivab pediatric SNDA acceptance By: Reuters: Company News June 05, 2017 at 06:36 AM EDT * Says snda has a pdufa goal date for a decision by end of september 2017 Source text for Eikon: Further company coverage: Read More >> Related Stocks: Biocryst Pharma Inc